Bio-Thera Solutions

NCT03030430

Study of Bevacizumab(BAT1706) and Comparators in Healthy Subjects

NCT04189211

A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients

NCT03606876

Comparative Study to Evaluate the Pharmacokinetics of BAT1806 vs Actemra® in Healthy Subjects

NCT04152148

A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients

NCT04151212

A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration

NCT03884517

Clinical Trial of BAT8003 (for Injection) for Patients With Advanced Epithelial Cancer

NCT04152759

Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects

NCT04371185

Comparative Study to Evaluate the Pharmacokinetics of BAT2206 vs Stelara® in Healthy Subjects

NCT04146285

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

NCT05155722

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy with BAT1308 in Advanced Solid Tumors

NCT05148325

Assessment of Safety ,Tolerance and Pharmacokinetics Clinical Efficacy With BAT4706 in Advanced Solid Tumors

NCT05073484

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients

NCT05116709

Assessment of Safety and Preliminary Clinical Efficacy with BAT6005 in Advanced Malignant Solid Tumors

NCT05105971

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in China

NCT05767060

BAT7104 Injection in Patients with Advanced Malignant Tumors.

NCT05414136

Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

NCT05120375

Assessment of Safety and Preliminary Efficacy With BAT6021 in Solid Tumor Patients in China

NCT05109650

Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumour Patients

NCT05200013

BAT7104 in Patients With Advanced Solid Tumours

NCT04711343

Comparative Study to Evaluate the Pharmacokinetics of BAT2306 vs Cosentyx® in Healthy Subjects

NCT05518695

Evaluate the Pharmacokinetics of BAT2022 in Healthy Chinese Subjects

NCT05378737

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8006 for Injection

NCT05332730

A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®

NCT05405621

Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009

NCT05576454

Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects

NCT05620017

Evaluate the Safety, Tolerability and Pharmacokinetic Characteristics of BAT8008 for Injection

NCT05879627

To Evaluate the Safety, Tolerance and Pharmacokinetics of BAT8007 for Injection in Patients With Advanced Solid Tumors

NCT05848466

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

NCT05865574

A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection

NCT05968508

A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects

NCT06111196

Compare the Pharmacokinetics and Safety of BAT3306 Injection Versus KEYTRUDA® Administered in Healthy Male Subjects

NCT06139536

Assessment of Safety, Tolerability and Pharmacokinetics With BAT4706 and BAT1308 in Advanced Solid Tumors Patients

NCT07180862

A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants